SuperworthLipocine shares outstanding LPCN
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 8.2M
- On a year earlier
- +53.5%
- more shares
Lipocine had 8.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 53.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 5.7M | +5% |
| FY2024 | 5.4M | +2% |
| FY2023 | 5.3M | +2% |
| FY2022 | 5.2M | +0% |
| FY2021 | 5.2M | +34% |
| FY2020 | 3.9M | +118% |
| FY2019 | 1.8M | +41% |
| FY2018 | 1.3M | +2% |
| FY2017 | 1.2M | +16% |
| FY2016 | 1.1M | +0% |
| FY2015 | 1.1M | +43% |
| FY2014 | 752.6K | +11% |
| FY2013 | 678.3K | +159% |
| FY2012 | 262.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 8.2M | +54% | |
| Q1 FY26 | 6.8M | +27% | |
| Q4 FY25 | 5.7M | +5% | |
| Q3 FY25 | 5.4M | +1% | |
| Q2 FY25 | 5.4M | +0% | |
| Q1 FY25 | 5.3M | −0% | |
| Q4 FY24 | 5.4M | +2% | |
| Q3 FY24 | 5.3M | +1% | |
| Q2 FY24 | 5.3M | +2% | |
| Q1 FY24 | 5.4M | +2% | |
| Q4 FY23 | 5.3M | +2% | |
| Q3 FY23 | 5.3M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Lipocine
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.